Form 4: CACI President & CEO Disposes of 10,175 Shares at Near $493
Rhea-AI Filing Summary
Insider sale by CEO and director John S. Mengucci: The Form 4 shows Mr. Mengucci sold 10,175 shares of CACI common stock on 09/15/2025 in multiple transactions at weighted-average prices ranging roughly from $490.29 to $493.96 per share. After these disposals his reported beneficial ownership declined from 111,678 shares to 101,536 shares.
The filing lists Mr. Mengucci as both President & CEO and a director and provides transaction-level price ranges for each grouped sale. No derivative transactions or other compensatory grants are reported in this Form 4. The form is signed by the reporting person on 09/16/2025.
Positive
- Timely and detailed disclosure of multiple open-market sales with weighted-average prices and post-sale holdings, supporting SEC Section 16 transparency.
- Clear role disclosure identifying the reporting person as both President & CEO and a director, improving governance clarity.
Negative
- Insider selling of 10,175 shares reduced the CEO's direct holdings by approximately 9.1%, which investors may view negatively absent an explained reason.
- No checkbox marked for a Rule 10b5-1 plan or other plan explanation in the filing, so the sales are not explicitly tied to a pre-established trading plan in this Form 4.
Insights
TL;DR: The CEO executed routine open-market sales totaling 10,175 shares at ~ $490–$494, reducing direct holdings modestly.
The transactions appear to be standard open-market dispositions across multiple trades, with weighted-average prices disclosed for each grouped sale. The total shares sold (10,175) reduced direct beneficial ownership from 111,678 to 101,536 shares, a decline of about 9.1%. There is no indication in this filing of option exercises, derivative activity, or any concurrent material corporate announcement. From a financial-materiality standpoint this is notable as insider selling volume but does not by itself reveal motive or signal a change in company fundamentals.
TL;DR: Disclosure is compliant and specific; insider sales are documented with price ranges and post-transaction holdings.
The Form 4 provides the necessary detail: transaction dates, codes, share counts, weighted-average prices, and post-transaction beneficial ownership. The reporting person checked the form as filed by one person and identified his roles. The filing includes explanations for the grouped trade price ranges and a signed disclosure dated 09/16/2025, which supports compliance with Section 16 reporting obligations. The filing does not assert a 10b5-1 plan box or other explanatory plan checkbox.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | CACI Common Stock | 33 | $490.29 | $16K |
| Sale | CACI Common Stock | 1,742 | $491.07 | $855K |
| Sale | CACI Common Stock | 1,443 | $492.28 | $710K |
| Sale | CACI Common Stock | 4,683 | $493.11 | $2.31M |
| Sale | CACI Common Stock | 2,274 | $493.96 | $1.12M |
Footnotes (1)
- This transaction was executed in multiple trades at prices ranging from $490.61 to $491.58. The prices reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $491.63 to $492.58. The prices reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $492.66 to $493.62. The prices reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $493.64 to $494.62. The prices reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.